Inspection Findings and Updates from FDA’s Office of Regulatory Affairs - Where Does Your Institution Rank Regarding the Most Cited Deficiencies?
8:30 AM - 9:30 AM CT
AM23-MN-02-L - Inspection Findings and Updates from FDA’s Office of Regulatory Affairs - Where Does Your Institution Rank Regarding the Most Cited Deficiencies?
Location: Room 209
Program Chair: Susan Turcovski – FDA Office of Regulatory Affairs Office of Biological Prdts Operations
New Plasma & Platelet Transfusion Guidance for Critically Ill Children by Transfusion Anemia Expert Initiative Control Avoidance of Bleeding, TAXI-CAB
8:30 AM - 9:30 AM CT
AM23-MN-07-L - New Plasma & Platelet Transfusion Guidance for Critically Ill Children by Transfusion Anemia Expert Initiative Control Avoidance of Bleeding, TAXI-CAB
OA1-AM23-MN-06 - Addressing racial disparities in donor pools: A workshop to guide medical student development in health advocacy by advancing equity across donation products
OA1-AM23-MN-13 - Age and sex differences in the red blood cell proteome highlight how donor factors may impact blood product quality: The BEST Collaborative Study
Location: Davidson Ballroom C3
Presenting Author: Tamir Kanias, PhD – Vitalant Research Institute; University of Colorado
Cell Biology, Immunology and Biochemistry (basic and preclinical research)
CE: Zero
10:00 AM - 11:00 AM CT
OA2-AM23-MN-13 - Metabolite levels from end of storage red blood cells are reproducible within the same donor across multiple donations
Cell Biology, Immunology and Biochemistry (basic and preclinical research)
CE: Zero
10:00 AM - 11:00 AM CT
OA3-AM23-MN-13 - Morphologically-altered Red Blood Cells that Accumulate During Storage Have Altered Proteostasis and Post-transfusion Spleen Retention
Immunohematology and Genetic Testing (red cells, leukocytes and platelets)
CE: Zero
2:00 PM - 3:00 PM CT
OA2-AM23-MN-20 - Effective Neutralization of evorpacept Anti-CD47 Reactivity in Pretransfusion Testing Using Evo-NR01, a Novel investigational Anti-idiotype Antibody
Immunohematology and Genetic Testing (red cells, leukocytes and platelets)
CE: Zero
3:30 PM - 5:00 PM CT
ASHI/AABB Joint Session: The Problem with Platelets: How perspectives of various practitioners involved in platelet support of refractory patients has led to continuing controversies
3:30 PM - 5:00 PM CT
AM23-MN-26-L - ASHI/AABB Joint Session: The Problem with Platelets: How Perspectives of Various Practitioners Involved in Platelet Support of Refractory Patients Has Led to Continuing Controversies
How to build a pre-hospital transfusion program between emergency medical services and a hospital-based transfusion service versus a blood center.
3:30 PM - 5:00 PM CT
AM23-MN-27-L - How to Build a Pre-Hospital Transfusion Program Between Emergency Medical Services and a Hospital-Based Transfusion Service Versus a Blood Center.
OA1-AM23-MN-23 - Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following periods of blood donor SARS-CoV-2 infection and vaccination
Location: Room 209
Presenting Author: Nareg Roubinian, MD – University of California San Francisco
Transfusion Service
CE: Zero
3:30 PM - 5:00 PM CT
OA2-AM23-MN-23 - Metabolomics analysis of over 13,000 donors from the REDS RBC Omics study identifies markers of hemolysis and in vivo hemoglobin increments
Cell Biology, Immunology and Biochemistry (basic and preclinical research)
CE: Zero
5:30 PM - 6:30 PM CT
OA2-AM23-MN-36 - A Re-evaluation of Washing Practice in the Chronically Transfused: Clinical and Laboratory Impact
Location: Davidson Ballroom C3
Presenting Author: Tait Huso, MD – Johns Hopkins University School of Medicine, Department of Pathology
Transfusion Service
CE: Zero
5:30 PM - 6:30 PM CT
OA3-AM23-MN-36 - Implementation Of 100% Pathogen-Reduced And Extension Of Shelf Life Of Platelet Concentrates In France: A Retrospective Study On Impact On Platelet Issuing
Location: Davidson Ballroom C3
Presenting Author: Pascale Richard – Etablissement Français du Sang
Transfusion Service
CE: Zero
5:30 PM - 6:30 PM CT
OA4-AM23-MN-36 - Modulation of Neutrophil Function by Red Cell Exchange in Patients with Sickle Cell Disease